Professor of Medicine, Dana-Farber Cancer Institute
Hematology
Dr. Joseph H. Antin, MD
|
|
Give Review
Joseph H. Antin, MD is an expert in the field of Hematology. He graduated from Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18/49 in Research/PrimaryCare. He has 6 awards "America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer", "Boston Herald", "Elected Member" and "Super Doctor". Joseph Antin is a published doctor as well. He has 100 publications published. The latest was: Circulating T follicular helper cells with increased function during chronic graft-versus-host-disease. Joseph Antin accepts all Medicare patients.
Publications
- Circulating T follicular helper Cells with increased function during chronic graft-versus-host-disease.
- Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis.
- A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A P...
- The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.
- Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions.
- The Utility of Routine Chest Radiography in the Initial Evaluation of Adult Patients With Febrile Neutropenia Patients Undergoing HSCT.
- A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality.
- Absolute Lymphocyte Count Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome.
- Myelodysplastic syndrome evolving from aplastic Anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation.
- Sequential infusion of donor-derived dendritic Cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem Cell transplan...
- Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloi...
- Risk Factors for Readmission after Allogeneic Hematopoietic Stem Cell Transplantation and Impact on Overall Survival.
- Characterization of Oral Involvement in Acute Graft-versus-Host Disease.
- A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-versus-Host Disease.
- Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2014.
- Long-Term Survival after Transplantation of Unrelated Donor Peripheral Blood or Bone Marrow Hematopoietic Cells for Hematologic Malignancy.
- Somatic mutations predict poor outcome in patients with myelodysplastic Syndrome after hematopoietic stem-cell transplantation.
- Outcomes and management strategies for Graft failure after umbilical cord blood transplantation.
- Phase III clinical trial steroids/mycophenolate mofetil vs steroids/placebo as therapy for Acute graft-versus-host disease: BMT CTN 0802.
- Tacrolimus/sirolimus versus tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic hematopoietic Cell transplantation.
- Donor Chimerism Early after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation Predicts Relapse and Survival.
- Hematopoietic stem Cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match doesn't exist.
- Increased T follicular helper Cells and germinal center B Cells are required for chronic GVHD (cGVHD) and bronchiolitis obliterans.
- Iron Overload in Allogeneic Hematopoietic Cell Transplantation Outcome: A Meta-Analysis.
- Factors associated with bronchiolitis obliterans Syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.
- Validation and refinement of the disease risk index for allogeneic stem Cell transplantation: a study from the CIBMTR.
- Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival.
- Live attenuated variCella-zoster vaccine in hematopoietic stem Cell transplantation recipients.
- Steroid-Refractory Acute Graft-versus-Host Disease: Is There an Effective Therapy?
- White blood Cell recovery after allogeneic hematopoietic Cell transplantation predicts clinical outcome.
- Post-Transplantation B Cell Activating Factor and B Cell Recovery before Onset of Chronic Graft-versus-Host Disease.
- BK Virus Disease after Allogeneic Stem Cell Transplantation: A Cohort Analysis.
- Reduced-intensity hematopoietic Cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow tran...
- Outcome and prognostic factors for patients who relapse after allogeneic hematopoietic stem Cell transplantation.
- Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem Cell transplantation for hematologic malignancies.
- Prostaglandin-modulated umbilical cord blood hematopoietic stem Cell transplantation.
- Outcomes of allogeneic hematopoietic Cell transplantation in patients with dyskeratosis congenita.
- ST2 as a marker for risk of therapy-resistant Graft-versus-host disease and death.
- Sequence-based discovery of Bradyrhizobium enterica in cord colitis Syndrome.
- Multicenter study of banked third party virus-specific T-Cells to treat severe viral infections after hematopoietic stem Cell transplantation.
- Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia.
- Low-dose interleukin-2 therapy restores regulatory T Cell homeostasis in patients with chronic graft-versus-host disease.
- Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial.
- A Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease.
- Low frequency clonal mutations recoverable by deep sequencing in Patients with aplastic Anemia.
- Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic Leukemia: prognostic model to predict outcome.
- KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation.
- Hepatic veno-occlusive disease after hematopoietic stem Cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions.
- Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem Cell transplantation.
- Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated Acute limbic encephalitis: a cohort analysis.
- Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive Disease.
- Phase II Trial of Parathyroid Hormone following Double Umbilical Cord Blood Transplantation.
- Does iron overload really matter in stem Cell transplantation?
- Allogeneic hematopoietic Cell transplantation for advanced polycythemia vera and essential thrombocythemia.
- Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic Cell transplantation.
- Interleukin-2 and regulatory T Cells in graft-versus-host disease.
- Donor B-Cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.
- Reduced-intensity conditioning stem Cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts.
- Risk factors for Acute GVHD and survival after hematopoietic cell transplantation.
- Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.
- Low telomerase activity in CD4+ regulatory T Cells in patients with severe chronic GVHD after hematopoietic stem Cell transplantation.
- The Impact of Geographic Proximity to Transplant Center on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation.
- Cord colitis Syndrome in cord-blood stem-cell transplantation.
- Risk factors associated with increased non-relapse mortality and with poor overall survival in children with Chronic graft-versus-host disease.
- Immune reconstitution after double umbilical cord blood stem Cell transplantation: comparison with unrelated peripheral blood stem Cell transplantation.
- Hyperlipidemia and Statin Use after Allogeneic Hematopoietic Stem Cell Transplantation.
- Classifying Cytogenetics in Patients with AML in Complete Remission Undergoing Allogeneic Transplantation: A CIBMTR Study.
- Patient Death Attributable to Implant-Related Primary Anaplastic Large Cell Lymphoma of the Breast: A Case Report and Review of the Literature.
- Combined CD4 T-Cell and Antibody Response to Human Minor Histocompatibility Antigen DBY After Allogeneic Stem-Cell Transplantation.
- Effect of stem cell source on outcomes after adult unrelated donor transplantation in severe aplastic Anemia.
- T-Cell depletion in GVHD: less is more?
- Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.
- Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment Syndrome.
- Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem Cell transplantation recipients.
- Optimization of therapy for severe aplastic Anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on sev...
- Recovery of B-Cell homeostasis after rituximab in chronic graft-versus-host disease.
- American journal of Cancer research: editorial board (2011).
- Launching of American Journal of Cancer Research.
- Invasive fungal Disease after remote inoculation in transplant recipients.
- Use of Matched Unrelated Donors Compared with Matched Related Donors Is Associated with Lower Relapse and Superior Progression-Free Survival after Reduced-Intensity Co...
- Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem Cell transplantation.
- Sirolimus immunosuppression for Graft-versus-host disease prophylaxis and therapy: an update.
- Iron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Transplantation.
- Prediction of veno-occlusive Disease using biomarkers of endothelial injury.
- The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acu...
- Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem Cell transplantation: a multicenter, randomized, dose-finding ...
- Donor-derived second hematologic malignancies after cord blood transplantation.
- Reduced-intensity conditioning hematopoietic stem Cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age.
- Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis.
- Altered regulatory T Cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem Cell transplantation.
- Diverse patterns of T-Cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
- Hepatic veno-occlusive disease following stem Cell transplantation: incidence, clinical course, and outcome.
- Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of Acute graft-versus-host disease?
- The 2010 Education Supplement on Hematopoietic Stem Cell Transplantation.
- Donor-recipient mismatch for common gene deletion polymorphisms in Graft-versus-host disease.
- Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem Cell transplantation from HL...
- Mental status changes after hematopoietic stem Cell transplantation.
- Biologic activity of irradiated, autologous, GM-CSF-secreting Leukemia cell vaccines early after allogeneic stem cell transplantation.
- Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of Acute intestinal graft-versus-host disease following allogeneic s...
Schools
Joan Sanford I Weill Medical College Of Cornell University
Peter Bent Brigham Hospital
Brigham WomensDana Farber
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Boston Herald
- Elected Member
- Super Doctor
Education
-
Brigham and Women's Hospital -
Weill Cornell Medical College of Cornell University
Hospital
-
Massachusetts General Hospital -
Dana-Farber Cancer Institute -
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1861469249 | |
| NPPES Provider LastName | ANTIN | |
| NPPES Provider FirstName | JOSEPH | |
| NPPES Provider ZIPCode | 021156013 | |
| NPPES Provider State | MA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1111.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861469249 |
| Last Name Of The Provider | ANTIN |
| First Name Of The Provider | JOSEPH |
| View All |
Similar Doctors
|
|
Dr. Martha Wadleigh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl J. O'Hara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marvin M. Adner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stefanie Sarantopoulos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marion F. Baxter, MD |
|
|
Dr. Margaret A. Shipp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Mayer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susana M. Campos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harold J. Burstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rasmia A. Khalid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew H. Kulke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric D. Jacobsen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philippe Armand, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zachary S. Spigelman, MD
This Doctor is OpenDoctor Recommended.
|